ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

NCT02670564 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

GENETIC: Pharmacogenomics
OTHER: Busulfan plasma level measurements

Sponsor

Swiss Pediatric Oncology Group

Collaborators

[object Object]